[1]
“Sandostatin therapy in patients with chronic sarcoidosis”, Sarcoidosis Vasc Diffuse Lung Dis, vol. 34, no. 3, pp. 269–271, Jan. 2018, doi: 10.36141/svdld.v34i3.6143.